Deep Unsupervised Domain Adaptation for Translating Cancer Dependency Maps From Cell Lines to Breast Cancer Tumor Genomics
Genetic Epidemiology · 2026
DOI: 10.1002/gepi.70044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetic Epidemiology, 2026. Verfasst von Yu Shi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics Division, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Breast Neoplasms, Genomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research.
Abstract (Originalsprache)
The Cancer dependency maps (DepMap) identify genetic dependencies in cancer cells using large‐scale loss‐of‐function screens, providing a foundation for cancer‐specific treatment strategies. However, discrepancies exist between cancer cell line models (CCLs) and patient‐derived tumor models, particularly in translating findings to clinical settings. To bridge this gap, computational approaches such as artificial intelligence–based domain adaptation can assist in aligning laboratory and patient‐derived molecular data, thereby improving the translation of preclinical findings into personalized treatment strategies. We developed a deep unsupervised domain adaptation (UDA) algorithm to align features between source and target domains. It was trained on labeled CCLs data from the source domain and unseen, unlabeled CCL data from the target domain. The trained model was applied to predict the dependency map of breast cancer (BC) patients in The Cancer Genome Atlas (TCGA). To validate its performance, we used the predicted BC dependency map to classify ER + /HER2 + BC subtype statuses and identify synthetic lethality (SL) gene pairs for drug discovery. Our model demonstrated high accuracy in predicting cancer dependency maps for patient‐derived tumors. The generated maps showed excellent performance in predicting ER + /HER2+ subtype statuses, with an area under the curve of the receiver operating characteristic (AUC‐ROC) of 0.99. Notably, our analysis also identified two potential synthetic lethality gene pairs: PBRM1‐NF2 and PBRM1‐CTNND2, which can be potentially used for developing precision therapies for ER + /HER2+ breast cancer. Domain adaptation is a promising approach for transferring biological knowledge between different cancer models and improving patient‐specific treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biostatistics Division, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
- Biostatistics Department, Princess Margaret Cancer Center, Toronto, Ontario, Canada.
- Department of Biochemistry, Western University, London, Ontario, Canada.
- Department of Computer Science, Western University, London, Ontario, Canada.
- Department of Oncology, Western University, London, Ontario, Canada.
- Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
ORCID-Profile: Pingzhao Hu
Förderung
- CIHR
- Natural Sciences and Engineering Research Council of Canada
- Canadian Institutes of Health Research
Zitieren
APA
Shi, Y., Xu, W., & Hu, P. (2026). Deep Unsupervised Domain Adaptation for Translating Cancer Dependency Maps From Cell Lines to Breast Cancer Tumor Genomics. Genetic Epidemiology. https://doi.org/10.1002/gepi.70044
Vancouver
Shi Y, Xu W, Hu P. Deep Unsupervised Domain Adaptation for Translating Cancer Dependency Maps From Cell Lines to Breast Cancer Tumor Genomics. Genetic Epidemiology. 2026. doi:10.1002/gepi.70044
BibTeX
@article{Shi2026,
author = {Shi, Yu and Xu, Wei and Hu, Pingzhao},
title = {Deep Unsupervised Domain Adaptation for Translating Cancer Dependency Maps From Cell Lines to Breast Cancer Tumor Genomics},
journal = {Genetic Epidemiology},
year = {2026},
doi = {10.1002/gepi.70044}
}
EUVIMED